Cargando…
Sodium (±)‐5‐bromo‐2‐(α‐hydroxypentyl) benzoate ameliorates pressure overload‐induced cardiac hypertrophy and dysfunction through inhibiting autophagy
Sodium (±)‐5‐bromo‐2‐(a‐hydroxypentyl) benzoate (generic name: brozopine, BZP) has been reported to protect against stroke‐induced brain injury and was approved for Phase II clinical trials for treatment of stroke‐related brain damage by the China Food and Drug Administration (CFDA). However, the ro...
Autores principales: | Wang, Bo, Shen, Deliang, Tang, Junnan, Li, Jing, Xiao, Yue, Chen, Xiuying, Cao, Chang, Han, Dongjian, Gao, Erhe, Zhao, Wen, Zhang, Jinying, Chang, Junbiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714213/ https://www.ncbi.nlm.nih.gov/pubmed/31222939 http://dx.doi.org/10.1111/jcmm.14468 |
Ejemplares similares
-
Protective Effects of Sodium (±)-5-Bromo-2-(α-Hydroxypentyl) Benzoate in a Rodent Model of Global Cerebral Ischemia
por: Gao, Yuan, et al.
Publicado: (2017) -
LC-MS/MS Analysis and Pharmacokinetics of Sodium (±)-5-Bromo-2-(α-hydroxypentyl) Benzoate (BZP), an Innovative Potent Anti-Ischemic Stroke Agent in Rats
por: Tian, Xin, et al.
Publicado: (2016) -
Preclinical Pharmacokinetics, Tissue Distribution, and Plasma Protein Binding of Sodium (±)-5-Bromo-2-(α-Hydroxypentyl) Benzoate (BZP), an Innovative Potent Anti-ischemic Stroke Agent
por: Tian, Xin, et al.
Publicado: (2016) -
Potassium 2-(1-hydroxypentyl)-benzoate improves depressive-like behaviors in rat model
por: Ma, Hao, et al.
Publicado: (2018) -
Potassium 2-(1-hydroxypentyl)-benzoate attenuates neuronal apoptosis in neuron–astrocyte co-culture system through neurotrophy and neuroinflammation pathway
por: Liu, Dongmei, et al.
Publicado: (2017)